Pharmaceutical Innovation: Can We Live Forever? A Commentary on Schnittker and Karandinos  

Oleh:

Lexchin, Joel

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Social Science & Medicine (www.elsevier.com/locate/sosscimed) vol. 70 no. 7 (Apr. 2010), page 972-973.
Topik: Pharmaceutical Innovation; Life Expectancy

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: SS53 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

If we discover enough new drugs can we live forever, or at least for a lot longer than we currently do? This is the thesis that Schnittker and Karandinos set out to explore in "Methuselah's Medicine: Pharmaceutical Innovation and Mortality in the United States, 1960-2000" in this issue of Social Science & Medicine the relationship between pharmaceutical innovation and life expectancy between 1960 and 2000 in the United States (U.S.). The amount of pharmaceutical innovation is measured by the number of new molecular entities (NME) approved by the Food and Drug Administration and mortality - life expectancy at birth and age-specific mortality - is examined as a function of NME approvals within a given year.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali